XONE Congressional Stock Trades
BONDBLOXX ETF TR 1 YR XONE
Last disclosed trade Oct 22
Every disclosed trade in XONE by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Charles J. "Chuck" Fleischmann · Sold $XONE · Jan 26 · $1K–$15K
Managed-account penalty applied (x 0.20): filings dominated by trust or wealth-manager activity are discounted.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $XONE
Get notified when any member of Congress trades $XONE. Free, no card, no spam.
The record on $XONE
Coldpine has parsed 5 disclosed trades in $XONE by 1 member of Congress, drawn from 5 periodic transaction reports dated Jul 21, 2023 through Oct 22, 2024. All of them came from House members, all filed by Republicans.
Of the 5 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 24 days. The longest was 29 days: a $XONE purchase by Charles J. "Chuck" Fleischmann dated Jul 18, 2024, disclosed Aug 16, 2024. How late filing is measured across all of Congress is in the late-filers study.
4 of the 4 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Activity peaked in 2024 with 3 trades.
Members who trade XONE
Recent disclosed trades in XONE
| Date | Member | Type | Amount |
|---|---|---|---|
| Oct 22 | Charles J. "Chuck" Fleischmann(TN) | sell | $15K–$50K |
| Jul 18 | Charles J. "Chuck" Fleischmann(TN) | buy | $1K–$15K |
| Jan 26 | Charles J. "Chuck" Fleischmann(TN) | sell | $1K–$15K |
| Oct 20 | Charles J. "Chuck" Fleischmann(TN) | sell | $1K–$15K |
| Jul 21 | Charles J. "Chuck" Fleischmann(TN) | buy | $1K–$15K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →